Hydrocortisone topical: Difference between revisions
Line 25: | Line 25: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*HPA axis suppresion | |||
*Cushing syndrome | |||
*hyperglycemia | |||
*intracranial HTN (peds pts) | |||
===Common=== | ===Common=== |
Revision as of 21:06, 26 June 2015
General
- Type: Topical steroid
- Dosage Forms: 0.5%, 1%, 2.5% crm, lotion, oint
- Common Trade Names:
Adult Dosing
dermatoses, steroid-responsive: apply bid-qid
Pediatric Dosing
dermatoses, steroid-responsive: apply bid-qid
Special Populations
- Pregnancy Rating: C
- Lactation: Probably safe
- Renal Dosing
- Adult: none
- Pediatric: none
- Hepatic Dosing
- Adult: none
- Pediatric: none
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- HPA axis suppresion
- Cushing syndrome
- hyperglycemia
- intracranial HTN (peds pts)
Common
Pharmacology
- Half-life: 8-12h
- Metabolism: liver primarily; CYP450
- Excretion: urine
- Mechanism of Action: exact mechanim of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple gluocorticoid and mineralocorticoid effects